Our Technology

Pioneering AI-powered chemoproteomics to revolutionize drug discovery. Our integrated platform combines cutting-edge machine learning with advanced proteomics for unprecedented insights.

Precision Targeting

Precision Targeting

AI algorithms identify therapeutic targets

Rapid Discovery

Rapid Discovery

10× faster than traditional methods

Comprehensive Analysis

Comprehensive Analysis

Full proteome coverage and interaction profiling

Our Platforms

Integrated Solutions

Powerful technologies working in harmony to accelerate your drug discovery

Javelin Platform
AI-Powered

Javelin

AI-Assisted Chemoproteomics Platform

Revolutionary protein target exploration platform combining mass spectrometry with machine learning for rapid target identification and validation.

  • Automated target identification
  • Real-time interaction mapping
  • Predictive binding analysis
  • Comprehensive safety profiling
Explore Javelin →
Drug Pipeline
In Development

Drug Pipeline

Therapeutic Development Portfolio

Our pipeline of innovative drug candidates across multiple therapeutic areas including autoimmune disease, anti-cancer, and metabolic disease.

  • Novel mechanism of action
  • Validated therapeutic targets
  • Pre-clinical optimization
  • Clinical development pathway
View Pipeline →
SynapSpec
Proteomics Solution

SynapSpec

Advanced Proteomics Technology Platform

Cutting-edge proteomics technology platform that accelerates drug discovery through deep learning optimization and real-time mass spectrometry analysis.

  • Deep learning-optimized workflows
  • Real-time data processing and analysis
  • Automated mass spectrometry optimization
  • Cross-platform compatibility
Visit SynapSpec →
Why Bionsight

Competitive Advantages

What sets our technology apart in the industry

4 Weeks

Faster Discovery

AI-driven target identification accelerates drug discovery timelines, enabling rapid validation of therapeutic candidates through automated analysis.

5000+

Protein Coverage

Comprehensive proteome-wide profiling captures thousands of protein targets simultaneously, revealing hidden drug mechanisms and off-target effects.

Versatile

Modality and Independent

Applicable across a wide range of therapeutic modalities with independent validation.

Insight

Structural Mapping

High-resolution binding site analysis pinpoints exact drug-protein interaction sites, guiding optimization for improved selectivity and efficacy.